One Day Advisor

By the One Day Advisor Editorial Team | Reviewed by Frank Yap, MBA | Originally published June 2025 | Updated October 2026 (Q3 2026 results through Roche’s October 22 sales release) Quick Answer: What are the largest pharma companies in the world? Johnson & Johnson is the world’s largest pharmaceutical/healthcare company by revenue ($94.2 billion in 2025), followed by China’s distributor Sinopharm Group (~$80 billion), Roche (~$70 billion), Eli Lilly ($65.2 billion, +45%), Merck & Co. ($65.0 billion), Pfizer ($62.6 billion), AbbVie ($61.2 billion), AstraZeneca ($58.7 billion), Novartis ($54.5 billion) and Bristol Myers Squibb ($48.2 billion). Lilly is the largest by market capitalization (~$1.1 trillion). J&J raised 2026 guidance to ~$101.2 billion on October 13. What changed in this October 22, 2026 update New: Q3 2026 results from Johnson & Johnson (Oct 13) and Roche (Oct 22), plus a Q3 reporting calendar for the rest of the top 10. Fixed: conflict...

Medically & Financially Reviewed by: Dr. Frank Yap, MD, MBA | Written by: OneDayAdvisor Editorial Team | Last Updated: October 2026 Quick Answer Merck & Co. remains the world's top cancer drug company by 2025 oncology revenue (~$35.4 billion, driven overwhelmingly by Keytruda) , followed by Roche (~$29–30 billion), AstraZeneca ($25.6 billion), Johnson & Johnson ($25.4 billion), and Bristol Myers Squibb (~$25.0 billion). Global oncology drug spending topped an estimated $291 billion in 2025 and is projected to reach roughly $467 billion by 2030 (IQVIA Institute), making cancer treatment the single largest therapeutic category in pharmaceuticals. The competitive picture keeps shifting: Merck's Keytruda faces a 2028 patent cliff, BMS's Revlimid has already lost roughly half its sales to generics, and a wave of Chinese-originated antibody-drug conjugates...